Rationale and design of Children’s Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States

Abstract Background The study purpose is to describe trajectories of financial distress for parents of children (ages 1–14.9 years) with newly diagnosed acute lymphoblastic leukemia (ALL). The secondary aim is to identify multilevel factors (child, parent, household, treating institution) that influ...

Full description

Bibliographic Details
Main Authors: Melissa Beauchemin, Sheila Judge Santacroce, Kira Bona, Ha Dang, Sarah Alexander, Kamala Allen, Crystal De Los Santos, Beth Fisher, Yudy Muñeton-Castaño, Olivia Ponce, Sarah Vargas, Aaron Sugalski, Lillian Sung, Susan Parsons
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Health Services Research
Subjects:
Online Access:https://doi.org/10.1186/s12913-022-08201-0
_version_ 1828468843816681472
author Melissa Beauchemin
Sheila Judge Santacroce
Kira Bona
Ha Dang
Sarah Alexander
Kamala Allen
Crystal De Los Santos
Beth Fisher
Yudy Muñeton-Castaño
Olivia Ponce
Sarah Vargas
Aaron Sugalski
Lillian Sung
Susan Parsons
author_facet Melissa Beauchemin
Sheila Judge Santacroce
Kira Bona
Ha Dang
Sarah Alexander
Kamala Allen
Crystal De Los Santos
Beth Fisher
Yudy Muñeton-Castaño
Olivia Ponce
Sarah Vargas
Aaron Sugalski
Lillian Sung
Susan Parsons
author_sort Melissa Beauchemin
collection DOAJ
description Abstract Background The study purpose is to describe trajectories of financial distress for parents of children (ages 1–14.9 years) with newly diagnosed acute lymphoblastic leukemia (ALL). The secondary aim is to identify multilevel factors (child, parent, household, treating institution) that influence change in financial distress over time. Methods The study uses a prospective cohort design, repeated measurements, and mixed methods. The settings are Children’s Oncology Group (COG) institutions participating in the National Cancer Institute Community Oncology Research Program (NCORP). Eligible participants are English- and/or Spanish-speaking parents or legal guardians (hereafter “parents”) of index children. Parents are asked to complete a survey during their child’s induction (T1) and maintenance therapy (T2), and near treatment completion (T3). Study surveys include items about (a) the child’s cancer and clinical course, (b) parental socio-economic status, financial distress and financial coping behaviors, and (c) household material hardships. At least 15 parents will be invited to participate in an optional semi-structured interview. NCORP institutions that enroll at least one parent must complete an annual survey about institution resources that could influence parental financial distress. Discussion The results will inform future interventions to mitigate financial distress for parents of children diagnosed with ALL and could be instructive beyond this disease group. Trial registration This trial was initially registered with the NCI Clinical Trial Reporting Program ID: NCI-2021–03,567 on June 16, 2021. The study can be found on clinicaltrials.gov, Identifier NCT04928599 .
first_indexed 2024-12-11T04:30:13Z
format Article
id doaj.art-5e6371e18b0d47b4999f5800a61a2bde
institution Directory Open Access Journal
issn 1472-6963
language English
last_indexed 2024-12-11T04:30:13Z
publishDate 2022-06-01
publisher BMC
record_format Article
series BMC Health Services Research
spelling doaj.art-5e6371e18b0d47b4999f5800a61a2bde2022-12-22T01:20:54ZengBMCBMC Health Services Research1472-69632022-06-0122111310.1186/s12913-022-08201-0Rationale and design of Children’s Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United StatesMelissa Beauchemin0Sheila Judge Santacroce1Kira Bona2Ha Dang3Sarah Alexander4Kamala Allen5Crystal De Los Santos6Beth Fisher7Yudy Muñeton-Castaño8Olivia Ponce9Sarah Vargas10Aaron Sugalski11Lillian Sung12Susan Parsons13Columbia University School of NursingSchool of Nursing, University of North Carolina Chapel HillDepartment of Pediatric Oncology, Division of Hematology/Oncology, Boston Children’s Hospital, Harvard Medical School, Dana-Farber Cancer InstituteDepartment of Population and Public Health Sciences, Keck School of Medicine of USCHospital for Sick ChildrenDepartment of Population and Public Health Sciences, Keck School of Medicine of USCDriscoll Children’s HospitalChildren’s Healthcare of AtlantaDana-Farber Cancer InstituteChildren’s Oncology GroupChildren’s Oncology GroupUniversity of Texas Health Science Center at San AntonioHospital for Sick ChildrenTufts Medical Center, Institute for Clinical Research and Health Policy StudiesAbstract Background The study purpose is to describe trajectories of financial distress for parents of children (ages 1–14.9 years) with newly diagnosed acute lymphoblastic leukemia (ALL). The secondary aim is to identify multilevel factors (child, parent, household, treating institution) that influence change in financial distress over time. Methods The study uses a prospective cohort design, repeated measurements, and mixed methods. The settings are Children’s Oncology Group (COG) institutions participating in the National Cancer Institute Community Oncology Research Program (NCORP). Eligible participants are English- and/or Spanish-speaking parents or legal guardians (hereafter “parents”) of index children. Parents are asked to complete a survey during their child’s induction (T1) and maintenance therapy (T2), and near treatment completion (T3). Study surveys include items about (a) the child’s cancer and clinical course, (b) parental socio-economic status, financial distress and financial coping behaviors, and (c) household material hardships. At least 15 parents will be invited to participate in an optional semi-structured interview. NCORP institutions that enroll at least one parent must complete an annual survey about institution resources that could influence parental financial distress. Discussion The results will inform future interventions to mitigate financial distress for parents of children diagnosed with ALL and could be instructive beyond this disease group. Trial registration This trial was initially registered with the NCI Clinical Trial Reporting Program ID: NCI-2021–03,567 on June 16, 2021. The study can be found on clinicaltrials.gov, Identifier NCT04928599 .https://doi.org/10.1186/s12913-022-08201-0Childhood allFinancial distressFinancial hardshipFinancial toxicityHealth outcomes
spellingShingle Melissa Beauchemin
Sheila Judge Santacroce
Kira Bona
Ha Dang
Sarah Alexander
Kamala Allen
Crystal De Los Santos
Beth Fisher
Yudy Muñeton-Castaño
Olivia Ponce
Sarah Vargas
Aaron Sugalski
Lillian Sung
Susan Parsons
Rationale and design of Children’s Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States
BMC Health Services Research
Childhood all
Financial distress
Financial hardship
Financial toxicity
Health outcomes
title Rationale and design of Children’s Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States
title_full Rationale and design of Children’s Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States
title_fullStr Rationale and design of Children’s Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States
title_full_unstemmed Rationale and design of Children’s Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States
title_short Rationale and design of Children’s Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States
title_sort rationale and design of children s oncology group cog study accl20n1cd financial distress during treatment of acute lymphoblastic leukemia in the united states
topic Childhood all
Financial distress
Financial hardship
Financial toxicity
Health outcomes
url https://doi.org/10.1186/s12913-022-08201-0
work_keys_str_mv AT melissabeauchemin rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT sheilajudgesantacroce rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT kirabona rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT hadang rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT sarahalexander rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT kamalaallen rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT crystaldelossantos rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT bethfisher rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT yudymunetoncastano rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT oliviaponce rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT sarahvargas rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT aaronsugalski rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT lilliansung rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates
AT susanparsons rationaleanddesignofchildrensoncologygroupcogstudyaccl20n1cdfinancialdistressduringtreatmentofacutelymphoblasticleukemiaintheunitedstates